EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Clinical trial NCT01360840 · COMPLETED

Trial details

NCT number: NCT01360840
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2011-04-01
Primary completion: 2013-04-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.